High-grade gliomas represent one of the most aggressive and treatment-resistant types of human brain cancer, with a median survival rate of only 14.6 months for patients with grade IV glioma (glioblastoma) [1,2].
Alzheimerâ€™s disease is a neurodegenerative disorder, involving memory loss which progressively worsens, eventually leading to death. Currently there is no cure and diagnosis is commonly based on a personâ€™s family history or expensive and intrusive detection methods.
Discovered nearly 30 years ago, exosomes are now being implicated in one of the most important and promising breakthroughs in medical therapy yet. A quick glance in PubMed reveals over ~3,000 journal references since their discovery in 1983.